首页|瓜蒌大黄汤治疗重症肺炎随机对照研究

瓜蒌大黄汤治疗重症肺炎随机对照研究

扫码查看
目的 探讨瓜蒌大黄汤早期灌肠对重症肺炎气分证患者发热程度、炎性因子、肠受损黏膜修复等影响。方法 将80例气分证重症肺炎发热患者按随机数字表法分为对照组和观察组,每组40例。两组均给予西医常规治疗,观察组在此基础上加用瓜蒌大黄汤灌肠,两组均持续治疗5天。记录两组患者治疗前、治疗第3天及第7天发热程度、白细胞(WBC)、中性粒细胞比率(NE%)、C-反应蛋白(CRP)、降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、血清二胺氧化酶(DAO)、胃动素(MTL)水平及中医证候评分,比较两组患者28天病死率、机械通气时间、ICU住院日及安全性指标。结果 与本组治疗前比较,对照组治疗第3天CRP、PCT水平及第7天六项炎性指标水平、血清DAO水平下降,MTL水平升高(P<0。05),第7天发热、咯痰、喘息评分及中医证候积分总分下降(P<0。05);观察组治疗第3天NE%、CRP、PCT、TNF-α水平及第7天六项炎性指标水平下降(P<0。05),治疗第3及第7天血清DAO水平下降,MTL水平升高(P<0。05),第7天发热、咳嗽、咯痰、喘息、腹胀、便秘评分及中医证候积分总分下降(P<0。05)。与对照组比较,观察组开始退热时间、首次降至正常体温时间、完全退热时间、体温复升率、复升后体温峰值降低(P<0。05);第7天WBC、NE%、CRP、IL-6、TNF-α水平及血清DAO水平降低,治疗第3天和第7天血清MTL水平升高(P<0。05);第7天发热、喘息、腹胀、便秘评分及中医证候积分总分降低(P<0。05)。两组患者治疗后28天病死率、ICU住院日、机械通气时间比较,差异无统计学意义(P>0。05)。各项安全性指标均未见明显异常,研究过程中未出现严重不良反应。结论 在西医常规疗法基础上加用瓜蒌大黄汤早期灌肠可使重症肺炎患者解除发热症状,减轻炎症反应,促进胃肠黏膜修复及功能恢复。
Gualou Dahuang Decoction in the Treatment of Severe Pneumonia:A Randomized Controlled Trial
Objective To observe the clinical effect of early enema with Gualou Dahuang Decoction on fever degree,inflammatory factors and epair of intestinal damaged mucosa in patients with severe pneumonia(SP).Methods Totally 80 febrile patients with SP of Qi syndrome were assigned to the observation group and the control group according to random number table,40 patients in each group.All patients received conventional Western medicine treatment,patients in the observation group additionally given Gualou Dahuang Decoction enema.The course of treatment in both groups was 5 days.The changes of the fever degree,white blood cell(WBC),neutrophil ratio(NE%),C-reactive protein(CRP),procalcitonin(PCT),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),serum diamine oxidase(DAO)and motilin(MTL),Chinese medicine(CM)syndrome score were recorded before treatment and on the 3rd and 7th day of treatment.28-day mortality,duration of mechanical ventilation,ICU stay and safety indicators were compared between the two groups.Results Compared with baseline,the levels of CRP and PCT on the 3rd day of treatment and the levels of six inflammatory factors,the serum DAO level on the 7th day reduced and the serum MTL level increased in the control group(P<0.05).On the 7th day,the scores of fever,expectoration,wheeze and the total score of CM syndrome decreased in the control group(P<0.05).While the levels of NE%,CRP,PCT,and TNF-α on the 3rd day of treatment,the levels of six inflammatory factors on the 7th day of treatment and the serum DAO level on the 3rd and 7th day of treatment decreased and at the same time the MTL level increased in the observation group(P<0.05).On the 7th day,the scores of fever,cough,expectoration,wheeze,abdominal distention,constipation and the total score of CM syndrome decreased in the observation group(P<0.05).Compared with the control group,the time of fever relief,the time of first reducation to normal temperature,the time of complete fever relief,the rate of temperature rerising and the peak temperature after rerising in the observation group were lower(P<0.05).The reduction degree of WBC,NE%,CRP,IL-6,TNF-α and the serum DAO on the 7th day reduced,and the MTL on the 3rd and 7th day of treatment increased(P<0.05).The reduction degree of fever,wheeze,abdominal distention,constipation and the total score of CM syndrome integral on the 7th day of treatment reduced(P<0.05).There was no significant difference in the 28-day mortality,ICU stay and mechanical ventilation time in both groups(P>0.05).And there was no obvious abnormalities in safety indicators.No obvious adverse reactions occurred in both groups during the treatment.Conclusion Early enema with Gualou Dahuang Decoction combined with Western medicine for the treatment of severe pneumonia can relieve fever,reduce inflammatory reaction,and promote the repair and functional recovery of gastrointestinal mucosal.

severe pneumoniaGualou Dahuang Decoctionpurgating Fu-organs to eliminate heatfeverChinese medicine enemarandomized controlled trial

王田田、邓扬嘉、孙小平

展开 >

重庆市中医院急诊重症医学科(重庆 400021)

重症肺炎 瓜蒌大黄汤 通腑泄热 发热 中药灌肠 随机对照试验

重庆市自然科学基金面上项目重庆市科卫联合中医药技术创新与应用发展项目

cstc2020 jcyjmsxmX10102020 ZY023689

2024

中国中西医结合杂志
中国中西医结合学会 中国中医科学院

中国中西医结合杂志

CSTPCD北大核心
影响因子:2.149
ISSN:1003-5370
年,卷(期):2024.44(4)
  • 39